Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jun 7;10(12):e32531. doi: 10.1016/j.heliyon.2024.e32531

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Authors. Published by Elsevier Ltd.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 13 — Differences in drug sensitivity between the two necroptosis subtypes. A-T Sensitivity of patients in the two necroptosis subtypes to the drugs KIN001.135 (A), imatinib (B), ATRA (C), CCT007093 (D), AG.014699 (E), AZD.0530 (F), BMS.708163 (G), PAC.1 (H), AZD6482 (I) gefitinib (J), Z.LLNle.CHO (K), X17.AAG (L), JNK.Inhibitor.VIII (M), AICAR (N), CGP.082996 (O), PHA.665752 (P), LFM.A13 (Q), WO2009093972 (R), bexarotene (S), and lapatinib (T) based on the data from Genomics of Drug Sensitivity in Cancer (GDSC). ***p < 0.001.